NEFL and amyotrophic lateral sclerosis: Investigations for unique ALS gene signatures compared to non-ALS controls led researchers to predict disease occurrence based on the combination of neurofilament-light (Nf-L) and neuroinflammatory biomarkers in the serum and cerebral spinal fluid these patients (Brodovitch et al., 2021).